Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67

This publication has 17 references indexed in Scilit:

• The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
  Gastroenterology, 1995
• Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
• Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.
  Journal of Clinical Investigation, 1995
• Cell kinetics in human breast cancer: Comparison between the prognostic value of the cytofluorimetric S‐phase fraction and that of the antibodies to Ki‐67 and PCNA antigens detected by immunocytochemistry
  International Journal of Cancer, 1994
• Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
  British Journal of Surgery, 1993
• Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1
  Histopathology, 1993
• Ki-67 Antibody Labeling Index in Colorectal Carcinoma
  Journal of Clinical Gastroenterology, 1992
• Expression of proliferation associated antigens in the cell cycle of synchronized mammalian cells
  Cytometry, 1992
• Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis.
  The Journal of cell biology, 1988
• Increased nuclear cyclin/PCNA antigen staining of non S‐phase transformed human amnion cells engaged in nucleotide excision DNA repair
  FEBS Letters, 1986